Discover
ESPR
Esperion Therapeutics, Inc.
3.16
100 x 3.15
2 x 4.05
bid
ask
+
0.00
0.00%
51 @ 04:57 AM
3.17 +0.01 (0.32%)
| Ytd | -14.59% | |
| 1y | 216.00% |
3.15
day range
3.17
1.00
52 week range
4.18
| Open | 3.17 | Prev Close | 3.16 | Low | 3.15 | High | 3.17 | Mkt Cap | 814.31M |
| Vol | 5.38M | Avg Vol | 13.19M | EPS | N/A | P/E | N/A | Forward P/E | 11.20 |
| Beta | 0.95 | Short Ratio | 5.70 | Inst. Own | 66.34% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 2.95 | 200-d Avg | 3.04 | 1yr Est | 7.51 |
| Income Statement | |||
| Total Revenue | 80.10M | ||
| Revenues (USD) | 80.10M | ||
| Cost of Revenue | 34.57M | ||
| Gross Profit | 45.53M | ||
| Operating Expenses | 52.11M | ||
| Research and Development Expense | 8.99M | ||
| Selling, General and Administrative Expense | 43.12M | ||
| Operating Income | -6.58M | ||
| Interest Expense | 19.80M | ||
| Net Income | -25.20M | ||
| Net Income Common Stock | -25.20M | ||
| Net Income Common Stock (USD) | -25.20M | ||
| Consolidated Income | -25.20M | ||
| Earnings per Basic Share | -0.10 | ||
| Earnings per Basic Share (USD) | -0.10 | ||
| Earnings per Diluted Share | -0.10 | ||
| Earning Before Interest & Taxes (EBIT) | -5.40M | ||
| Earning Before Interest & Taxes (USD) | -5.40M | ||
| Weighted Average Shares | 251.35M | ||
| Weighted Average Shares Diluted | 251.35M | ||
| Balance Sheet | |||
| Cash and Equivalents | 156.16M | ||
| Cash and Equivalents (USD) | 156.16M | ||
| Trade and Non-Trade Receivables | 132.35M | ||
| Current Assets | 459.46M | ||
| Property, Plant & Equipment Net | 3.01M | ||
| Total Assets | 462.53M | ||
| Debt Current | 82.45M | ||
| Total Debt | 543.81M | ||
| Current Liabilities | 300.36M | ||
| Debt Non-Current | 461.36M | ||
| Total Liabilities | 770.46M | ||
| Accumulated Retained Earnings (Deficit) | -1.65B | ||
| Shareholders Equity | -307.93M | ||
| Shareholders Equity (USD) | -307.93M | ||
| Assets Non-Current | 3.07M | ||
| Total Debt (USD) | 543.81M | ||
| Deferred Revenue | 43.53M | ||
| Goodwill and Intangible Assets | 56.00K | ||
| Inventory | 104.21M | ||
| Liabilities Non-Current | 470.10M | ||
| Trade and Non-Trade Payables | 68.41M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 27.00K | ||
| Net Cash Flow from Financing | 16.22M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -11.69M | ||
| Capital Expenditure | -189.00K | ||
| Issuance (Purchase) of Equity Shares | 16.22M | ||
| Net Cash Flow from Investing | -189.00K | ||
| Net Cash Flow from Operations | -27.72M | ||
| Share Based Compensation | 2.50M | ||